Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 28, 2012; 18(40): 5771-5778
Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5771
Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5771
Table 1 Baseline clinical characteristics of patients with intestinal Behcet’s disease
Characteristic | No. of patient (%) |
Age at diagnosis of BD (yr) | 38.5 ± 12.2 |
Age at diagnosis of intestinal BD (yr) | 41.4 ± 12.3 |
Gender (male:female) | 71:96 (42.5:57.5) |
Systemic symptoms and signs of BD | |
Recurrent oral ulcer | 159 (95.2) |
Recurrent genital ulcer | 78 (46.7) |
Ocular lesion | 10 (6.0) |
Skin lesion | 82 (49.1) |
Positive pathergy test | 4 (2.4) |
Arthritis or arthralgia | 66 (39.5) |
Neurologic lesion | 0 |
Vascular lesion | 2 (1.2) |
Clinical subtype of BD | |
Complete | 3 (1.8) |
Incomplete | 78 (46.7) |
Suspected | 53 (31.7) |
Symptoms and signs of intestinal involvement | |
Abdominal pain | 120 (71.8) |
Diarrhea | 142 (85.0) |
Abdominal mass | 4 (2.4) |
Tenderness | 119 (71.2) |
Nausea/vomiting | 4 (2.4) |
Melena/hematochezia | 31 (18.6) |
Fistula | 4 (2.4) |
Stenosis (intestinal obstruction) | 10 (6.0) |
Abscess | 0 |
Perforation | 0 |
Current use of medication | |
5-ASA or sulfasalazine | 163 (97.6) |
Azathioprine or 6-mercaptopurine | 24 (14.4) |
Colchicine | 80 (47.9) |
Corticosteroid | 72 (43.1) |
Patient global assessment | |
Well | 63 (37.7) |
Mild | 53 (31.7) |
Moderate | 45 (26.9) |
Severe | 6 (3.6) |
DAIBD | 74.9 ± 36.1 (5-155) |
Quiescent ( ≤ 19) | 2 (1.2) |
Mild (20-39) | 32 (19.2) |
Moderate (40-74) | 50 (29.9) |
Severe (≥ 75) | 83 (49.7) |
Table 2 Baseline colonoscopic characteristics of patients with intestinal Behcet’s disease
Characteristic | No. of patient (%) |
Location of intestinal lesion | 4 (2.4) |
Ileal area | 156 (93.4) |
Ileocecal area | 25 (15.0) |
Ascending colon | 18 (10.8) |
Other colonic segment | |
Distribution of intestinal lesion | |
Localized involvement | 142 (85.0) |
Diffuse involvement | 25 (15.0) |
Number of intestinal ulcer | |
Solitary | 86 (51.5) |
2-5 | 53 (31.7) |
≥ 5 | 28 (16.8) |
Depth of intestinal ulcer | |
Aphthous | 12 (7.2) |
Shallow | 46 (27.5) |
Deep | 109 (65.3) |
Shape of intestinal ulcer | |
Oval | 79 (47.3) |
Geographic | 52 (31.1) |
Volcano | 36 (21.6) |
Size of intestinal ulcer (mm) | |
< 5 | 11 (6.6) |
5-10 | 29 (17.4) |
10-20 | 45 (26.9) |
≥ 20 | 82 (49.1) |
Margin of intestinal ulcer | |
Discrete | 75 (44.9) |
Elevation | 13 (7.8) |
Nodular elevation | 32 (19.2) |
Marginal erythema | 47 (28.1) |
Type of intestinal ulcer | |
Typical type | 94 (56.3) |
Atypical type | 73 (43.7) |
Diagnostic criteria of intestinal BD | |
Definite | 69 (41.3) |
Probable | 82 (49.1) |
Suspected | 16 (9.6) |
Table 3 Univariate analysis of endoscopic factors associated with the disease activity index for intestinal Behcet’s disease
Endoscopic factor | DAIBD (mean ± SD) | F/t value | P value |
Location | 0.48 | 0.632 | |
Ileocecal area | 74.58 ± 36.74 | ||
Other | 80.00 ± 26.08 | ||
Distribution | |||
Localized | 73.98 ± 35.22 | -0.82 | 0.414 |
Diffuse | 80.40 ± 41.10 | ||
Number of intestinal ulcer | 0.39 | 0.679 | |
Solitary | 72.67 ± 30.92 | ||
2- 5 | 76.51 ± 41.75 | ||
≥ 5 | 78.93 ± 40.08 | ||
Depth of intestinal ulcer | 5.03 | 0.008 | |
Aphthous | 57.08 ± 37.02 | ||
Shallow | 65.00 ± 30.09 | ||
Deep | 81.10 ± 37.01 | ||
Shape of intestinal ulcer | 13.33 | < 0.001 | |
Oval | 65.13 ± 37.79 | ||
Geographic | 72.60 ± 28.40 | ||
Volcano | 99.86 ± 30.95 | ||
Size of intestinal ulcer (mm) | 6.62 | < 0.001 | |
< 5 | 52.73 ± 35.45 | ||
5-10 | 69.48 ± 36.38 | ||
10-20 | 63.00 ± 33.02 | ||
≥ 20 | 86.40 ± 34.29 | ||
Margin of intestinal ulcer | 1.95 | 0.124 | |
Discrete | 80.47 ± 37.70 | ||
Elevation | 56.54 ± 33.63 | ||
Nodular elevation | 75.47 ± 29.93 | ||
Marginal erythema | 70.85 ± 36.81 |
Table 4 Multivariate analysis of endoscopic factors associated with the disease activity index for intestinal Behcet’s disease
Endoscopic factor | βcoefficient | P value |
Intercept | 47.44 | |
Location | ||
Ileocecal area | 0 | |
Other | 9.04 | 0.389 |
Number of intestinal ulcer | ||
Solitary | 0 | |
≥ 2 | 11.85 | 0.031 |
Depth of intestinal ulcer | ||
Aphthous | 0 | |
Shallow | 5.03 | 0.651 |
Deep | 12.76 | 0.261 |
Shape of intestinal ulcer | ||
Oval | 0 | |
Geographic | 4.47 | 0.495 |
Volcano | 26.93 | 0.001 |
Size of intestinal ulcer (mm) | ||
< 20 | 0 | |
≥ 20 | 8.65 | 0.225 |
Table 5 Predicted and actual disease activity index for intestinal Behcet’s disease scores in intestinal Behcet’s disease patients
Actual DAIBD | Predicted DAIBD by an endoscopic model | Total | |||
Quiescent ( ≤19) | Mild (20-39) | Moderate (40-74) | Severe (≥75) | ||
Quiescent ( ≤ 19) | 0 | 0 | 1 | 1 | 2 |
Mild (20-39) | 0 | 0 | 28 | 4 | 32 |
Moderate (40-74) | 0 | 0 | 37 | 13 | 50 |
Severe (≥ 75) | 0 | 0 | 42 | 41 | 83 |
Total | 0 | 0 | 108 | 59 | 167 |
- Citation: Lee HJ, Kim YN, Jang HW, Jeon HH, Jung ES, Park SJ, Hong SP, Kim TI, Kim WH, Nam CM, Cheon JH. Correlations between endoscopic and clinical disease activity indices in intestinal Behcet's disease. World J Gastroenterol 2012; 18(40): 5771-5778
- URL: https://www.wjgnet.com/1007-9327/full/v18/i40/5771.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i40.5771